We know that adherence is the key to prevention and treatment. But how do we ensure adherence in the face of the myriad individual, structural, financial, psychological, and social barriers that HIV-positive people need to overcome?
How do we make HIV prevention work? There’s plenty of theoretical knowledge; transforming knowledge into sustainable practice is the challenge. For longstanding biomedical prevention methods or new approaches alike, one critical component underlies sustainable HIV prevention: adherence.
Who is most impacted by HIV in the United States, and what are the promising policies and interventions that can help reduce new infections and improve the health and well-being of those living with HIV? Stewart Landers, Director of JSI/Boston, offers insight and a thank you to those who have fought to end the epidemic.
Today, effective HIV prevention and treatment methods are available to more people around the world than ever before, however challenges in the fight to end the epidemic and improve the lives of people living with HIV still lie ahead. On World AIDS Day, JSI’s Andrew Fullem celebrates the opportunities to continue global progress toward an AIDS-free generation.
HIV still has no cure or vaccine, but current tools, if used at scale and in combination, can help us achieve an AIDS-free generation by 2030. JSI’s Dr. Samson Kironde, Director of the AIDSFree Project, explains the global strategy, tactics, and best practices that are helping set the path for an end to HIV.
The Every Dose, Every Day online toolkit developed by CDC and AIDS.gov offers assistance to both health care providers and people with HIV to improve medication adherence.
The latest WHO guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV prevention could have major implications for people living with HIV and those at greatest risk for contracting the virus. JSI’s Samson Kironde, Director of the AIDSFree project explains that in order to realize the guidelines’ potential, global investments must be made to overcome the remaining challenges to ending the HIV epidemic.